Baudax Bio Probability of Future Stock Price Finishing Over 0.51
| BXRXDelisted Stock | USD 0.76 0.06 7.32% |
Baudax |
Baudax Bio Target Price Odds to finish over 0.51
The tendency of Baudax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0.51 in 90 days |
| 0.76 | 90 days | 0.51 | about 74.75 |
Based on a normal probability distribution, the odds of Baudax Bio to stay above $ 0.51 in 90 days from now is about 74.75 (This Baudax Bio probability density function shows the probability of Baudax Stock to fall within a particular range of prices over 90 days) . Probability of Baudax Bio price to stay between $ 0.51 and its current price of $0.76 at the end of the 90-day period is about 20.32 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.92 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Baudax Bio will likely underperform. Additionally Baudax Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Baudax Bio Price Density |
| Price |
Predictive Modules for Baudax Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Baudax Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Baudax Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Baudax Bio is not an exception. The market had few large corrections towards the Baudax Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Baudax Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Baudax Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.59 | |
β | Beta against Dow Jones | 1.92 | |
σ | Overall volatility | 0.45 | |
Ir | Information ratio | -0.03 |
Baudax Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Baudax Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Baudax Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Baudax Bio is not yet fully synchronised with the market data | |
| Baudax Bio has some characteristics of a very speculative penny stock | |
| Baudax Bio has a very high chance of going through financial distress in the upcoming years | |
| Baudax Bio currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax Bio has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Baudax Bio's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M). | |
| Baudax Bio currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. |
Baudax Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Baudax Stock often depends not only on the future outlook of the current and potential Baudax Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Baudax Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 331.6 K | |
| Cash And Short Term Investments | 5.3 M |
Baudax Bio Technical Analysis
Baudax Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Baudax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Baudax Bio. In general, you should focus on analyzing Baudax Stock price patterns and their correlations with different microeconomic environments and drivers.
Baudax Bio Predictive Forecast Models
Baudax Bio's time-series forecasting models is one of many Baudax Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Baudax Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Baudax Bio
Checking the ongoing alerts about Baudax Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Baudax Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Baudax Bio is not yet fully synchronised with the market data | |
| Baudax Bio has some characteristics of a very speculative penny stock | |
| Baudax Bio has a very high chance of going through financial distress in the upcoming years | |
| Baudax Bio currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax Bio has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Baudax Bio's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M). | |
| Baudax Bio currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Baudax Stock
If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |